nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.11	0.248	CbGbCtD
Solifenacin—CYP3A4—Triamcinolone—psoriatic arthritis	0.083	0.188	CbGbCtD
Solifenacin—CYP3A4—Betamethasone—psoriatic arthritis	0.0712	0.161	CbGbCtD
Solifenacin—CYP3A4—Prednisolone—psoriatic arthritis	0.0703	0.159	CbGbCtD
Solifenacin—CYP3A4—Prednisone—psoriatic arthritis	0.0664	0.15	CbGbCtD
Solifenacin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0414	0.0937	CbGbCtD
Solifenacin—Benazepril—ACE—psoriatic arthritis	0.0345	1	CrCbGaD
Solifenacin—Obstructive airways disorder—Methotrexate—psoriatic arthritis	0.0155	0.0295	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.0139	0.0266	CcSEcCtD
Solifenacin—Eye disorder—Auranofin—psoriatic arthritis	0.00851	0.0162	CcSEcCtD
Solifenacin—Dysgeusia—Auranofin—psoriatic arthritis	0.00776	0.0148	CcSEcCtD
Solifenacin—Glaucoma—Prednisolone—psoriatic arthritis	0.00767	0.0147	CcSEcCtD
Solifenacin—Angioedema—Auranofin—psoriatic arthritis	0.00724	0.0138	CcSEcCtD
Solifenacin—Glaucoma—Triamcinolone—psoriatic arthritis	0.00706	0.0135	CcSEcCtD
Solifenacin—Glaucoma—Methylprednisolone—psoriatic arthritis	0.00704	0.0135	CcSEcCtD
Solifenacin—Glaucoma—Betamethasone—psoriatic arthritis	0.0064	0.0122	CcSEcCtD
Solifenacin—Glaucoma—Dexamethasone—psoriatic arthritis	0.0064	0.0122	CcSEcCtD
Solifenacin—Dyspepsia—Auranofin—psoriatic arthritis	0.00569	0.0109	CcSEcCtD
Solifenacin—Decreased appetite—Auranofin—psoriatic arthritis	0.00562	0.0107	CcSEcCtD
Solifenacin—Glaucoma—Prednisone—psoriatic arthritis	0.00558	0.0107	CcSEcCtD
Solifenacin—Constipation—Auranofin—psoriatic arthritis	0.00553	0.0106	CcSEcCtD
Solifenacin—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00529	0.0101	CcSEcCtD
Solifenacin—Liver disorder—Methotrexate—psoriatic arthritis	0.00515	0.00984	CcSEcCtD
Solifenacin—Urticaria—Auranofin—psoriatic arthritis	0.00514	0.00981	CcSEcCtD
Solifenacin—Abdominal pain—Auranofin—psoriatic arthritis	0.00511	0.00977	CcSEcCtD
Solifenacin—Delirium—Prednisone—psoriatic arthritis	0.00488	0.00933	CcSEcCtD
Solifenacin—Pruritus—Auranofin—psoriatic arthritis	0.00458	0.00874	CcSEcCtD
Solifenacin—Dry eye—Betamethasone—psoriatic arthritis	0.00445	0.00851	CcSEcCtD
Solifenacin—Dry eye—Dexamethasone—psoriatic arthritis	0.00445	0.00851	CcSEcCtD
Solifenacin—Vomiting—Auranofin—psoriatic arthritis	0.00411	0.00785	CcSEcCtD
Solifenacin—Rash—Auranofin—psoriatic arthritis	0.00408	0.00779	CcSEcCtD
Solifenacin—Dermatitis—Auranofin—psoriatic arthritis	0.00407	0.00778	CcSEcCtD
Solifenacin—Dry skin—Prednisolone—psoriatic arthritis	0.00385	0.00735	CcSEcCtD
Solifenacin—Nausea—Auranofin—psoriatic arthritis	0.00384	0.00734	CcSEcCtD
Solifenacin—Muscular weakness—Prednisolone—psoriatic arthritis	0.0037	0.00707	CcSEcCtD
Solifenacin—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.00343	0.00655	CcSEcCtD
Solifenacin—Muscular weakness—Triamcinolone—psoriatic arthritis	0.0034	0.0065	CcSEcCtD
Solifenacin—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00339	0.00649	CcSEcCtD
Solifenacin—Cystitis—Methotrexate—psoriatic arthritis	0.00339	0.00647	CcSEcCtD
Solifenacin—Influenza—Triamcinolone—psoriatic arthritis	0.00333	0.00637	CcSEcCtD
Solifenacin—Dry skin—Dexamethasone—psoriatic arthritis	0.00321	0.00613	CcSEcCtD
Solifenacin—Dry skin—Betamethasone—psoriatic arthritis	0.00321	0.00613	CcSEcCtD
Solifenacin—Bladder pain—Methotrexate—psoriatic arthritis	0.00317	0.00606	CcSEcCtD
Solifenacin—Muscular weakness—Betamethasone—psoriatic arthritis	0.00309	0.0059	CcSEcCtD
Solifenacin—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00309	0.0059	CcSEcCtD
Solifenacin—Infestation—Methylprednisolone—psoriatic arthritis	0.00297	0.00567	CcSEcCtD
Solifenacin—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00297	0.00567	CcSEcCtD
Solifenacin—Dry skin—Prednisone—psoriatic arthritis	0.00279	0.00534	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.0027	0.00516	CcSEcCtD
Solifenacin—Muscular weakness—Prednisone—psoriatic arthritis	0.00269	0.00514	CcSEcCtD
Solifenacin—Hallucination—Methylprednisolone—psoriatic arthritis	0.00265	0.00506	CcSEcCtD
Solifenacin—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00265	0.00506	CcSEcCtD
Solifenacin—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00262	0.005	CcSEcCtD
Solifenacin—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00249	0.00475	CcSEcCtD
Solifenacin—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00247	0.00472	CcSEcCtD
Solifenacin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00242	0.00462	CcSEcCtD
Solifenacin—Hallucination—Dexamethasone—psoriatic arthritis	0.00241	0.0046	CcSEcCtD
Solifenacin—Hallucination—Betamethasone—psoriatic arthritis	0.00241	0.0046	CcSEcCtD
Solifenacin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00241	0.00459	CcSEcCtD
Solifenacin—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.0024	0.00458	CcSEcCtD
Solifenacin—Vision blurred—Prednisolone—psoriatic arthritis	0.00238	0.00455	CcSEcCtD
Solifenacin—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00235	0.00449	CcSEcCtD
Solifenacin—Depression—Prednisone—psoriatic arthritis	0.00234	0.00447	CcSEcCtD
Solifenacin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00233	0.00446	CcSEcCtD
Solifenacin—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00232	0.00443	CcSEcCtD
Solifenacin—Angioedema—Prednisolone—psoriatic arthritis	0.00231	0.00441	CcSEcCtD
Solifenacin—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00228	0.00435	CcSEcCtD
Solifenacin—Eye disorder—Betamethasone—psoriatic arthritis	0.00226	0.00432	CcSEcCtD
Solifenacin—Eye disorder—Dexamethasone—psoriatic arthritis	0.00226	0.00432	CcSEcCtD
Solifenacin—Angiopathy—Betamethasone—psoriatic arthritis	0.0022	0.0042	CcSEcCtD
Solifenacin—Angiopathy—Dexamethasone—psoriatic arthritis	0.0022	0.0042	CcSEcCtD
Solifenacin—Hypertension—Prednisolone—psoriatic arthritis	0.00218	0.00417	CcSEcCtD
Solifenacin—Angioedema—Triamcinolone—psoriatic arthritis	0.00212	0.00406	CcSEcCtD
Solifenacin—Angioedema—Methylprednisolone—psoriatic arthritis	0.00212	0.00405	CcSEcCtD
Solifenacin—Hallucination—Prednisone—psoriatic arthritis	0.0021	0.00401	CcSEcCtD
Solifenacin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00207	0.00396	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00206	0.00394	CcSEcCtD
Solifenacin—Dysuria—Methotrexate—psoriatic arthritis	0.00206	0.00393	CcSEcCtD
Solifenacin—Cough—Triamcinolone—psoriatic arthritis	0.00203	0.00387	CcSEcCtD
Solifenacin—Tachycardia—Prednisolone—psoriatic arthritis	0.00201	0.00384	CcSEcCtD
Solifenacin—Hypertension—Triamcinolone—psoriatic arthritis	0.00201	0.00383	CcSEcCtD
Solifenacin—Hypertension—Methylprednisolone—psoriatic arthritis	0.002	0.00382	CcSEcCtD
Solifenacin—Eye disorder—Prednisone—psoriatic arthritis	0.00197	0.00376	CcSEcCtD
Solifenacin—Infestation—Methotrexate—psoriatic arthritis	0.00196	0.00375	CcSEcCtD
Solifenacin—Infestation NOS—Methotrexate—psoriatic arthritis	0.00196	0.00375	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00196	0.00374	CcSEcCtD
Solifenacin—Depression—Methotrexate—psoriatic arthritis	0.00196	0.00374	CcSEcCtD
Solifenacin—Dry mouth—Triamcinolone—psoriatic arthritis	0.00193	0.0037	CcSEcCtD
Solifenacin—Renal failure—Methotrexate—psoriatic arthritis	0.00193	0.00369	CcSEcCtD
Solifenacin—Angioedema—Dexamethasone—psoriatic arthritis	0.00193	0.00368	CcSEcCtD
Solifenacin—Angioedema—Betamethasone—psoriatic arthritis	0.00193	0.00368	CcSEcCtD
Solifenacin—Angiopathy—Prednisone—psoriatic arthritis	0.00191	0.00366	CcSEcCtD
Solifenacin—Confusional state—Methylprednisolone—psoriatic arthritis	0.00191	0.00364	CcSEcCtD
Solifenacin—Immune system disorder—Prednisone—psoriatic arthritis	0.0019	0.00364	CcSEcCtD
Solifenacin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.0019	0.00362	CcSEcCtD
Solifenacin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00189	0.00361	CcSEcCtD
Solifenacin—Infection—Triamcinolone—psoriatic arthritis	0.00188	0.0036	CcSEcCtD
Solifenacin—Infection—Methylprednisolone—psoriatic arthritis	0.00188	0.00359	CcSEcCtD
Solifenacin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00186	0.00355	CcSEcCtD
Solifenacin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00186	0.00354	CcSEcCtD
Solifenacin—Tachycardia—Triamcinolone—psoriatic arthritis	0.00185	0.00354	CcSEcCtD
Solifenacin—Mental disorder—Prednisone—psoriatic arthritis	0.00185	0.00353	CcSEcCtD
Solifenacin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00185	0.00353	CcSEcCtD
Solifenacin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00184	0.00351	CcSEcCtD
Solifenacin—Malnutrition—Prednisone—psoriatic arthritis	0.00184	0.00351	CcSEcCtD
Solifenacin—Hypertension—Dexamethasone—psoriatic arthritis	0.00182	0.00348	CcSEcCtD
Solifenacin—Hypertension—Betamethasone—psoriatic arthritis	0.00182	0.00348	CcSEcCtD
Solifenacin—Pharyngitis—Methotrexate—psoriatic arthritis	0.00175	0.00334	CcSEcCtD
Solifenacin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00174	0.00333	CcSEcCtD
Solifenacin—Vision blurred—Prednisone—psoriatic arthritis	0.00173	0.00331	CcSEcCtD
Solifenacin—Urethral disorder—Methotrexate—psoriatic arthritis	0.00173	0.0033	CcSEcCtD
Solifenacin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00172	0.00329	CcSEcCtD
Solifenacin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00172	0.00329	CcSEcCtD
Solifenacin—Infection—Betamethasone—psoriatic arthritis	0.00171	0.00327	CcSEcCtD
Solifenacin—Infection—Dexamethasone—psoriatic arthritis	0.00171	0.00327	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.0017	0.00325	CcSEcCtD
Solifenacin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00169	0.00322	CcSEcCtD
Solifenacin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00169	0.00322	CcSEcCtD
Solifenacin—Tachycardia—Dexamethasone—psoriatic arthritis	0.00168	0.00321	CcSEcCtD
Solifenacin—Tachycardia—Betamethasone—psoriatic arthritis	0.00168	0.00321	CcSEcCtD
Solifenacin—Angioedema—Prednisone—psoriatic arthritis	0.00168	0.0032	CcSEcCtD
Solifenacin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00167	0.00319	CcSEcCtD
Solifenacin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00167	0.00318	CcSEcCtD
Solifenacin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00167	0.00318	CcSEcCtD
Solifenacin—Eye disorder—Methotrexate—psoriatic arthritis	0.00165	0.00315	CcSEcCtD
Solifenacin—Urticaria—Prednisolone—psoriatic arthritis	0.00164	0.00313	CcSEcCtD
Solifenacin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00164	0.00312	CcSEcCtD
Solifenacin—Fatigue—Triamcinolone—psoriatic arthritis	0.00163	0.00312	CcSEcCtD
Solifenacin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00163	0.00312	CcSEcCtD
Solifenacin—Angiopathy—Methotrexate—psoriatic arthritis	0.0016	0.00305	CcSEcCtD
Solifenacin—Immune system disorder—Methotrexate—psoriatic arthritis	0.00159	0.00304	CcSEcCtD
Solifenacin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00159	0.00303	CcSEcCtD
Solifenacin—Hypertension—Prednisone—psoriatic arthritis	0.00159	0.00303	CcSEcCtD
Solifenacin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00156	0.00298	CcSEcCtD
Solifenacin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00156	0.00298	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00155	0.00297	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00155	0.00296	CcSEcCtD
Solifenacin—Mental disorder—Methotrexate—psoriatic arthritis	0.00154	0.00295	CcSEcCtD
Solifenacin—Malnutrition—Methotrexate—psoriatic arthritis	0.00153	0.00293	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00152	0.0029	CcSEcCtD
Solifenacin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00151	0.00289	CcSEcCtD
Solifenacin—Dyspepsia—Betamethasone—psoriatic arthritis	0.00151	0.00289	CcSEcCtD
Solifenacin—Urticaria—Triamcinolone—psoriatic arthritis	0.00151	0.00288	CcSEcCtD
Solifenacin—Urticaria—Methylprednisolone—psoriatic arthritis	0.0015	0.00287	CcSEcCtD
Solifenacin—Dysgeusia—Methotrexate—psoriatic arthritis	0.0015	0.00287	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.0015	0.00286	CcSEcCtD
Solifenacin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.0015	0.00286	CcSEcCtD
Solifenacin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.0015	0.00286	CcSEcCtD
Solifenacin—Decreased appetite—Betamethasone—psoriatic arthritis	0.0015	0.00286	CcSEcCtD
Solifenacin—Infection—Prednisone—psoriatic arthritis	0.00149	0.00284	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00149	0.00284	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00149	0.00284	CcSEcCtD
Solifenacin—Fatigue—Betamethasone—psoriatic arthritis	0.00148	0.00283	CcSEcCtD
Solifenacin—Fatigue—Dexamethasone—psoriatic arthritis	0.00148	0.00283	CcSEcCtD
Solifenacin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00147	0.00281	CcSEcCtD
Solifenacin—Tachycardia—Prednisone—psoriatic arthritis	0.00146	0.00279	CcSEcCtD
Solifenacin—Skin disorder—Prednisone—psoriatic arthritis	0.00146	0.00278	CcSEcCtD
Solifenacin—Vision blurred—Methotrexate—psoriatic arthritis	0.00145	0.00276	CcSEcCtD
Solifenacin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00142	0.00271	CcSEcCtD
Solifenacin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00142	0.00271	CcSEcCtD
Solifenacin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00141	0.00269	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00141	0.00269	CcSEcCtD
Solifenacin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0014	0.00267	CcSEcCtD
Solifenacin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00139	0.00266	CcSEcCtD
Solifenacin—Urticaria—Dexamethasone—psoriatic arthritis	0.00137	0.00261	CcSEcCtD
Solifenacin—Urticaria—Betamethasone—psoriatic arthritis	0.00137	0.00261	CcSEcCtD
Solifenacin—Dizziness—Prednisolone—psoriatic arthritis	0.00136	0.0026	CcSEcCtD
Solifenacin—Asthenia—Triamcinolone—psoriatic arthritis	0.00136	0.0026	CcSEcCtD
Solifenacin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00136	0.0026	CcSEcCtD
Solifenacin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00136	0.0026	CcSEcCtD
Solifenacin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00136	0.00259	CcSEcCtD
Solifenacin—Pruritus—Triamcinolone—psoriatic arthritis	0.00134	0.00256	CcSEcCtD
Solifenacin—Cough—Methotrexate—psoriatic arthritis	0.00134	0.00256	CcSEcCtD
Solifenacin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00134	0.00256	CcSEcCtD
Solifenacin—Dyspepsia—Prednisone—psoriatic arthritis	0.00132	0.00252	CcSEcCtD
Solifenacin—Decreased appetite—Prednisone—psoriatic arthritis	0.0013	0.00249	CcSEcCtD
Solifenacin—Rash—Prednisolone—psoriatic arthritis	0.0013	0.00248	CcSEcCtD
Solifenacin—Dermatitis—Prednisolone—psoriatic arthritis	0.0013	0.00248	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.0013	0.00248	CcSEcCtD
Solifenacin—Fatigue—Prednisone—psoriatic arthritis	0.00129	0.00247	CcSEcCtD
Solifenacin—Headache—Prednisolone—psoriatic arthritis	0.00129	0.00247	CcSEcCtD
Solifenacin—Constipation—Prednisone—psoriatic arthritis	0.00128	0.00245	CcSEcCtD
Solifenacin—Confusional state—Methotrexate—psoriatic arthritis	0.00126	0.00241	CcSEcCtD
Solifenacin—Dizziness—Triamcinolone—psoriatic arthritis	0.00125	0.0024	CcSEcCtD
Solifenacin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00125	0.00239	CcSEcCtD
Solifenacin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00125	0.00239	CcSEcCtD
Solifenacin—Infection—Methotrexate—psoriatic arthritis	0.00124	0.00238	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00123	0.00236	CcSEcCtD
Solifenacin—Asthenia—Dexamethasone—psoriatic arthritis	0.00123	0.00236	CcSEcCtD
Solifenacin—Asthenia—Betamethasone—psoriatic arthritis	0.00123	0.00236	CcSEcCtD
Solifenacin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00123	0.00235	CcSEcCtD
Solifenacin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00123	0.00234	CcSEcCtD
Solifenacin—Nausea—Prednisolone—psoriatic arthritis	0.00122	0.00234	CcSEcCtD
Solifenacin—Pruritus—Dexamethasone—psoriatic arthritis	0.00122	0.00233	CcSEcCtD
Solifenacin—Pruritus—Betamethasone—psoriatic arthritis	0.00122	0.00233	CcSEcCtD
Solifenacin—Skin disorder—Methotrexate—psoriatic arthritis	0.00122	0.00232	CcSEcCtD
Solifenacin—Vomiting—Triamcinolone—psoriatic arthritis	0.00121	0.0023	CcSEcCtD
Solifenacin—Vomiting—Methylprednisolone—psoriatic arthritis	0.0012	0.0023	CcSEcCtD
Solifenacin—Rash—Triamcinolone—psoriatic arthritis	0.0012	0.00228	CcSEcCtD
Solifenacin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00119	0.00228	CcSEcCtD
Solifenacin—Rash—Methylprednisolone—psoriatic arthritis	0.00119	0.00228	CcSEcCtD
Solifenacin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00119	0.00228	CcSEcCtD
Solifenacin—Urticaria—Prednisone—psoriatic arthritis	0.00119	0.00227	CcSEcCtD
Solifenacin—Headache—Triamcinolone—psoriatic arthritis	0.00119	0.00227	CcSEcCtD
Solifenacin—Headache—Methylprednisolone—psoriatic arthritis	0.00119	0.00226	CcSEcCtD
Solifenacin—Abdominal pain—Prednisone—psoriatic arthritis	0.00118	0.00226	CcSEcCtD
Solifenacin—Dizziness—Betamethasone—psoriatic arthritis	0.00114	0.00217	CcSEcCtD
Solifenacin—Dizziness—Dexamethasone—psoriatic arthritis	0.00114	0.00217	CcSEcCtD
Solifenacin—Nausea—Triamcinolone—psoriatic arthritis	0.00113	0.00215	CcSEcCtD
Solifenacin—Nausea—Methylprednisolone—psoriatic arthritis	0.00112	0.00215	CcSEcCtD
Solifenacin—Somnolence—Methotrexate—psoriatic arthritis	0.00111	0.00213	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisone—psoriatic arthritis	0.0011	0.00211	CcSEcCtD
Solifenacin—Dyspepsia—Methotrexate—psoriatic arthritis	0.0011	0.00211	CcSEcCtD
Solifenacin—Vomiting—Dexamethasone—psoriatic arthritis	0.00109	0.00209	CcSEcCtD
Solifenacin—Vomiting—Betamethasone—psoriatic arthritis	0.00109	0.00209	CcSEcCtD
Solifenacin—Decreased appetite—Methotrexate—psoriatic arthritis	0.00109	0.00208	CcSEcCtD
Solifenacin—Rash—Dexamethasone—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Solifenacin—Rash—Betamethasone—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Solifenacin—Dermatitis—Betamethasone—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Solifenacin—Dermatitis—Dexamethasone—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Solifenacin—Fatigue—Methotrexate—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Solifenacin—Headache—Betamethasone—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Solifenacin—Headache—Dexamethasone—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Solifenacin—Asthenia—Prednisone—psoriatic arthritis	0.00107	0.00205	CcSEcCtD
Solifenacin—Pruritus—Prednisone—psoriatic arthritis	0.00106	0.00203	CcSEcCtD
Solifenacin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00103	0.00197	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00102	0.00196	CcSEcCtD
Solifenacin—Nausea—Betamethasone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Solifenacin—Nausea—Dexamethasone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Solifenacin—Urticaria—Methotrexate—psoriatic arthritis	0.000995	0.0019	CcSEcCtD
Solifenacin—Dizziness—Prednisone—psoriatic arthritis	0.000991	0.00189	CcSEcCtD
Solifenacin—Abdominal pain—Methotrexate—psoriatic arthritis	0.00099	0.00189	CcSEcCtD
Solifenacin—Vomiting—Prednisone—psoriatic arthritis	0.000953	0.00182	CcSEcCtD
Solifenacin—Rash—Prednisone—psoriatic arthritis	0.000945	0.0018	CcSEcCtD
Solifenacin—Dermatitis—Prednisone—psoriatic arthritis	0.000944	0.0018	CcSEcCtD
Solifenacin—Headache—Prednisone—psoriatic arthritis	0.000939	0.00179	CcSEcCtD
Solifenacin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000923	0.00176	CcSEcCtD
Solifenacin—Asthenia—Methotrexate—psoriatic arthritis	0.000898	0.00172	CcSEcCtD
Solifenacin—Nausea—Prednisone—psoriatic arthritis	0.00089	0.0017	CcSEcCtD
Solifenacin—Pruritus—Methotrexate—psoriatic arthritis	0.000886	0.00169	CcSEcCtD
Solifenacin—Dizziness—Methotrexate—psoriatic arthritis	0.000828	0.00158	CcSEcCtD
Solifenacin—Vomiting—Methotrexate—psoriatic arthritis	0.000796	0.00152	CcSEcCtD
Solifenacin—Rash—Methotrexate—psoriatic arthritis	0.00079	0.00151	CcSEcCtD
Solifenacin—Dermatitis—Methotrexate—psoriatic arthritis	0.000789	0.00151	CcSEcCtD
Solifenacin—Headache—Methotrexate—psoriatic arthritis	0.000784	0.0015	CcSEcCtD
Solifenacin—Nausea—Methotrexate—psoriatic arthritis	0.000744	0.00142	CcSEcCtD
